4 Steps to Deploy a Cybersecurity Postmarket Strategy
While the development of innovative technologies and connected devices continues to flourish, public concern surrounding cybersecurity has increased significantly in recent years.
read moreTips from Corporate Strategy Experts
As the medical device industry changes, companies are looking to achieve sustainable growth and business development.
read moreWhat Is Healthy?
With the new regulations, industry professionals have the unique opportunity to explain themselves and be clear about what claims are important for health today.
read moreUnderstanding and Incorporating ICH E6(R2)
In November 2016, ICH published an addendum to its guidelines for clinical practice, prompting pharmaceutical companies to align current clinical quality procedures with a risk-based monitoring approach.
read moreSterilization Recap
The following is a Q&A, featuring attendee feedback from the 3rd Semi-Annual Medical Device Sterilization Conference
read moreDoreen Taylor – Haemonetics
6th Semi-Annual Medical Device Supplier Quality Conference: Speaker Interview
read moreJoerg Pantermoller – Biotronik
5th Semi-Annual Medical Device Supplier Quality Conference Speaker Interview:
read moreFDA Previews Digital Health FastTrack Program
The FDA unveiled its program for digital health approvals this week. Named the Digital Health Innovation Action Plan, the program aims to speed up approval processes for digital health software which functions differently and poses a lower risk to health...
read moreTrump to Decide on Long Awaited Insurance Subsidies
President Trump has confirmed that he will decide whether to fund cost-sharing subsidies for lower-income Americans on Obamacare. The subsidies would offset high medical bills, enabling more Americans to afford their healthcare. A decision against funding...
read moreHumana Reports Profit Increase in Medicare Business
After a shift in business focus towards Medicare, Humana has announced an increase in profits. The insurer noted that after sustained losses in the Obamacare market, improving their Medicare Advantage business has helped the company increase 2017 profits...
read moreBristol Myers Squibb Receives FDA Approval for Colorectal Cancer Drug
Bristol Myers Squibb has secured FDA approval for its cancer drug, Opdivo, to fight microsatellite instability-high colorectal cancer this week after doubts about its ability to fight lung cancer. This form of colorectal cancer affects only 5% of...
read moreCONTACT US
Q1 Productions
1 W Monroe St 4th Floor
Chicago, IL 60603
T: +1 (312) 822-8100
hello@q1productions.com




